Cybin (HELP) Liabilities and Shareholders Equity (2021 - 2025)

Cybin (HELP) reported Liabilities and Shareholders Equity of $180.2 million for Q1 2025, down 19.59% on a YoY basis from $224.1 million in Q1 2024, and down 0.7% quarter-over-quarter from $181.5 million in Q4 2024.

Cybin (HELP) Liabilities and Shareholders Equity (2021 - 2025) Analysis & Trends

Cybin has reported Liabilities and Shareholders Equity for 5 years, with the latest figure at $180.2 million in Q1 2025.

  • For the quarter ending Q1 2025, Liabilities and Shareholders Equity fell 19.59% year-over-year to $180.2 million; the trailing twelve-month figure through Jun 2025 stood at $554.1 million (down 2.88% YoY), and the FY2025 full-year result was $186.0 million, down 17.0% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2025 stood at $180.2 million, down from $181.5 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $224.1 million in Q1 2024, with the low at $33.8 million in Q1 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $107.5 million across 5 years, with a median of $75.5 million in 2021.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity plunged 40.77% — and 2024, when it soared 347.47%.
  • Cybin's Liabilities and Shareholders Equity stood at $75.5 million in 2021, then sank by 40.77% to $44.7 million in 2022, then surged by 113.11% to $95.3 million in 2023, then soared by 90.48% to $181.5 million in 2024, then slipped by 0.7% to $180.2 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $180.2 million (Q1 2025), $181.5 million (Q4 2024), and $192.3 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Cybin 75.42 Mn 75.42 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 180.24 Mn
Dec 31, 2024 181.50 Mn
Sep 30, 2024 192.35 Mn
Jun 30, 2024 208.12 Mn
Mar 31, 2024 224.14 Mn
Dec 31, 2023 95.29 Mn
Sep 30, 2023 42.99 Mn
Jun 30, 2023 57.54 Mn
Feb 28, 2023 33.80 Mn
Dec 31, 2022 44.71 Mn
Sep 30, 2022 52.99 Mn
Dec 31, 2021 75.49 Mn
Sep 30, 2021 83.78 Mn
Jun 30, 2021 67.39 Mn
Mar 31, 2021 72.78 Mn